Tag: CAR-T
TGA OKs Novartis CAR-T cell therapy manufacturing in Melbourne
With TGA approval in check, Melbourne will house Australia's first and only commercial manufacturing site for the promising cancer treatment.
Swiss pharmaceutical company Novartis announced...
Featured Article
Australian manufacturing in 2025: Challenges and pathways to progress
The Australian manufacturing sector, long considered the backbone of the nation’s economy, is standing at a crossroads in 2025.
